Search Result "capreomycin"
Characterization of Radiolabeled Dry Powder Leucine, a Constituent of Inhalable Capreomycin
Journal: Drug Delivery Letters
Volume: 2 Issue: 3 Year: 2012 Page: 155-161
Author(s): Lindie Venter,Judith Wagener,P. Bernard Fourie,Jan Rijn Zeevaart
Treatment of Drug Resistant Tuberculosis
Ebook: Drug Resistant Tuberculosis
Volume: 1 Year: 2015
Author(s): Rafael Laniado-LaborÃn
Doi: 10.2174/9781681080666115010009
Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1177-1185
Author(s): Ruiru Shi, Nobunori Itagaki, Isamu Sugawara
Therapy of XDR TB with Thioridazine a Drug Beyond Patent Protection but Eligible for Patent “As New Use”
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 5 Issue: 2 Year: 2010 Page: 109-114
Author(s): Leonard Amaral, Joseph Molnar
Involvement of Molecular Mechanism and Biological Activities of Pemirolast: ATherapeutic Review
Journal: New Emirates Medical Journal
Volume: 5 Issue: 0 Year: 2024 Page: 1-16
Author(s):
Safety and Efficacy of Thioridazine as Salvage Therapy in Indian Patients with XDR-TB
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 88-91
Author(s): Zarir F. Udwadia, Tiyas Sen, Lancelot M. Pinto
Inhaled Dry Powder Formulations for Treating Tuberculosis
Journal: Current Drug Delivery
Volume: 12 Issue: 1 Year: 2015 Page: 26-39
Author(s): Shyamal Das,Ian Tucker,Peter Stewart
Thioridazine: Alternative and Potentially Effective Therapy of the XDRTB Patient
Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 2 Year: 2011 Page: 130-132
Author(s): Leonard Amaral, Marta Martins, Miguel Viveiros
The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control
Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 73-91
Author(s): Robert C. Goldman, Kevin V. Plumley, Barbara E. Laughon
Machine Learning and Tubercular Drug Target Recognition
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 4307-4318
Author(s): Li M. Fu